These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32959982)

  • 1. Elimination profiles of microdosed ostarine mimicking contaminated products ingestion.
    Walpurgis K; Rubio A; Wagener F; Krug O; Knoop A; Görgens C; Guddat S; Thevis M
    Drug Test Anal; 2020 Nov; 12(11-12):1570-1580. PubMed ID: 32959982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro and In Vivo Human Metabolism of Ostarine, a Selective Androgen Receptor Modulator and Doping Agent.
    Taoussi O; Bambagiotti G; Gameli PS; Daziani G; Tavoletta F; Tini A; Basile G; Lo Faro AF; Carlier J
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body fluid contamination in the context of an adverse analytical finding in doping: About a case involving ostarine.
    Alvarez JC; Etting I; Larabi IA
    Clin Chim Acta; 2024 Apr; 557():117871. PubMed ID: 38467244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
    Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
    Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of ostarine excretion in oral fluid after a single controlled oral administration.
    Kintz P; Gheddar L; Garnier D
    Clin Chim Acta; 2024 Apr; 557():117879. PubMed ID: 38499138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of S22 (ostarine) in human nails and hair using LC-HRMS. Application to two authentic cases.
    Kintz P; Gheddar L; Ameline A; Raul JS
    Drug Test Anal; 2020 Oct; 12(10):1508-1513. PubMed ID: 32688441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete.
    Kintz P
    J Pharm Biomed Anal; 2022 Jan; 207():114433. PubMed ID: 34715583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport.
    Bohlin KP; Pohanka A; Andersson A; Villén T; Ekström L
    Drug Test Anal; 2024 Aug; 16(8):827-834. PubMed ID: 37986708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical strategies to detect enobosarm administration in bovines.
    Cesbron N; Sydor A; Penot M; Prevost S; Le Bizec B; Dervilly-Pinel G
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2017 Apr; 34(4):632-640. PubMed ID: 27827563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of ostarine cross-contamination via sweat in 2 athletes sharing the same neoprene hamstring sleeves. An original situation of drug transfer where the anti-doping rule violation was suspended by the sport authorities.
    Kintz P; Gheddar L
    Clin Chim Acta; 2024 Jun; 559():119688. PubMed ID: 38670521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple incidence of the prescription diuretic hydrochlorothiazide in compounded nutritional supplements.
    Favretto D; Visentin S; Scrivano S; Roselli E; Mattiazzi F; Pertile R; Vogliardi S; Tucci M; Montisci M
    Drug Test Anal; 2019 Mar; 11(3):512-522. PubMed ID: 30194914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of designer doping agent--2-ethylamino-1-phenylbutane--in dietary supplements and excretion study following single oral supplement dose.
    Wójtowicz M; Jarek A; Chajewska K; Turek-Lepa E; Kwiatkowska D
    J Pharm Biomed Anal; 2015 Nov; 115():523-33. PubMed ID: 26311473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction.
    Sobolevsky T; Ahrens B
    Drug Test Anal; 2021 Feb; 13(2):283-298. PubMed ID: 32852861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes.
    Wagener F; Guddat S; Görgens C; Angelis YS; Petrou M; Lagojda A; Kühne D; Thevis M
    Anal Bioanal Chem; 2022 Jan; 414(2):1151-1162. PubMed ID: 34734312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes.
    Thevis M; Thomas A; Piper T; Krug O; Delahaut P; Schänzer W
    Eur J Mass Spectrom (Chichester); 2014; 20(1):73-83. PubMed ID: 24881457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
    Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
    Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens.
    Thevis M; Gerace E; Thomas A; Beuck S; Geyer H; Schlörer N; Kearbey JD; Dalton JT; Schänzer W
    Drug Test Anal; 2010; 2(11-12):589-98. PubMed ID: 20967890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control.
    Garg N; Hansson A; Knych HK; Stanley SD; Thevis M; Bondesson U; Hedeland M; Globisch D
    Org Biomol Chem; 2018 Jan; 16(5):698-702. PubMed ID: 29319101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the metabolism of the selective androgen receptor modulator LGD-4033 in equine urine, plasma and hair following oral administration.
    Cutler C; Viljanto M; Hincks P; Habershon-Butcher J; Muir T; Biddle S
    Drug Test Anal; 2020 Feb; 12(2):247-260. PubMed ID: 31655494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of stanozolol O- and N-sulfate metabolites and their evaluation as additional markers in doping control.
    Balcells G; Matabosch X; Ventura R
    Drug Test Anal; 2017 Jul; 9(7):1001-1010. PubMed ID: 27714936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.